Featured Research

from universities, journals, and other organizations

Circular RNAs more common than previously thought: Unexpected mode of gene expression is surprisingly widespread

Date:
February 1, 2012
Source:
Public Library of Science
Summary:
It may be time to revise this traditional understanding of human gene expression, as new research suggests that circular RNA molecules, rather than the classical linear molecules, are a widespread feature of the gene expression program in every human cell.

In the classical model of gene expression, the genetic script encoded in our genomes is expressed in each cell in the form of RNA molecules, each consisting of a linear string of chemical "bases." It may be time to revise this traditional understanding of human gene expression, as new research suggests that circular RNA molecules, rather than the classical linear molecules, are a widespread feature of the gene expression program in every human cell.

The results are published in the Feb. 1 issue of the online journal PLoS ONE.

A group of researchers working with HHMI investigator and biochemistry professor Patrick Brown, of Stanford University, have discovered hundreds of human gene transcripts that appear to have resulted from a non-canonical program that "splices" the RNA molecules into circles. For many genes, these circular RNAs made up a substantial fraction of all the transcripts identified, suggesting that they are far more abundant and perhaps more important than previously thought. Circular RNAs have heretofore "flown under the radar" because traditional methods for isolating RNA from cells have inadvertently discarded these circular molecules. The exact function of circular RNAs, and potential relevance for human biology or health, if any, remains to be determined, but this study opens up many exciting avenues for further research.

"This research shows that there are still important fundamental biological programs to be discovered by experimental exploration coupled with new statistical and computational approaches," said Julia Salzman, one of the authors of the paper. "These circular RNAs may represent a yet-to-be discovered biological process."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Julia Salzman, Charles Gawad, Peter Lincoln Wang, Norman Lacayo, Patrick O. Brown. Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types. PLoS ONE, 2012; 7 (2): e30733 DOI: 10.1371/journal.pone.0030733

Cite This Page:

Public Library of Science. "Circular RNAs more common than previously thought: Unexpected mode of gene expression is surprisingly widespread." ScienceDaily. ScienceDaily, 1 February 2012. <www.sciencedaily.com/releases/2012/02/120201180614.htm>.
Public Library of Science. (2012, February 1). Circular RNAs more common than previously thought: Unexpected mode of gene expression is surprisingly widespread. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/02/120201180614.htm
Public Library of Science. "Circular RNAs more common than previously thought: Unexpected mode of gene expression is surprisingly widespread." ScienceDaily. www.sciencedaily.com/releases/2012/02/120201180614.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins